Trevi Therapeutics (TRVI) Tops Q3 EPS by 6c
Trevi Therapeutics (NASDAQ: TRVI) reported Q3 EPS of ($0.34), $0.06 better than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Trevi Therapeutics (TRVI) click here.
Trevi Therapeutics (NASDAQ: TRVI) reported Q3 EPS of ($0.34), $0.06 better than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Trevi Therapeutics (TRVI) click here.